The kidney and ear: emerging parallel functions

Annual Review of Medicine

Volumn 60, Issue , 2009, Pages 339-353

  Torban, Elena ^a   Goodyer, Paul ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Deafness; Nephrotoxicity; Ototoxicity; Renal dysplasia

Indexed keywords

CISPLATIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GENTAMICIN; NUCLEAR PROTEIN; PROTEIN EYA1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR PAX2; TRANSCRIPTION FACTOR PAX8; TRANSCRIPTION FACTOR SALL1; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; WNT PROTEIN;

ACUTE KIDNEY FAILURE; ALPORT SYNDROME; ALSTROM SYNDROME; AUTOSOMAL DOMINANT DISORDER; BARDET BIEDL SYNDROME; BARTTER SYNDROME; BRANCIOOTORENAL SYNDROME; CYSTIC FIBROSIS; DISEASE ASSOCIATION; EAR MALFORMATION; EXTERNAL EAR MALFORMATION; GENE MUTATION; HEARING IMPAIRMENT; HEARING LOSS; HUMAN; HYPOPARATHYROIDISM; KALLMANN SYNDROME; KIDNEY DEVELOPMENT; KIDNEY DYSPLASIA; KIDNEY TUBULE ACIDOSIS; NEPHRONOPHTHISIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TOWNES BROCKS SYNDROME;

EAR; EAR DISEASES; HUMANS; KIDNEY; KIDNEY DISEASES; MUTATION; PHARMACEUTICAL PREPARATIONS; SYNDROME;

EID: 67650720730     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.60.052307.120752     Document Type: Review

References (100)

1. Deshpande SA, Watson H. 2006. Renal ultrasonography not required in babies with isolated minor ear anomalies. Arch. Dis. Child. Fetal Neonatal. Ed. 91(1):F29-30
2. Cuestas E, Bur C, Bongiovanni V. 2006. Mild external ear malformations and renal tract abnormalities: a meta-analysis. Rev. Fac. Cien. Med. Univ. Nac. Cordoba 63(1):46-52
3. Lizama M, Cavagnaro F, Arau R, et al. 2007. Association of isolated preauricular tags and nephrourological anomalies: case-control study. Pediatr. Nephrol. 22(5):658-60
4. Wang RY, Earl DL, Ruder RO, et al. 2001. Syndromic ear anomalies and renal ultrasounds. Pediatrics 108(2):E32
5. Kelley MW. 2006. Hair cell development: commitment through differentiation. Brain Res. 1091(1):172-85
6. Xu PX, Adams J, Peters H, et al. 1999. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat. Genet. 23(1):113-17
7. Zou D, Silvius D, Rodrigo-Blomqvist S, et al. 2006. Eya1 regulates the growth of otic epithelium and interacts with Pax2 during the development of all sensory areas in the inner ear. Dev. Biol. 298(2):430-41
8. Zheng W, Huang L,Wei ZB, et al. 2003. The role of Six1 in mammalian auditory system development. Development 130(17):3989-4000
9. Lawoko-Kerali G, Rivolta MN, Holley M. 2002. Expression of the transcription factors GATA3 and Pax2 during development of the mammalian inner ear. J. Comp. Neurol. 442(4):378-91
10. Burton Q, Cole LK, Mulheisen M, et al. 2004. The role of Pax2 in mouse inner ear development. Dev. Biol. 272(1):161-75
11. Grote D, Souabni A, Busslinger M, et al. 2006. Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney. Development 133(1):53-61
12. Brophy PD, Ostrom L, Lang KM, et al. 2001. Regulation of ureteric bud outgrowth by Pax2-dependent activation of the glial derived neurotrophic factor gene. Development 128(23):4747-56
13. Torres M, Gomez-Pardo E, Gruss P. 1996. Pax2 contributes to inner ear patterning and optic nerve trajectory. Development 122(11):3381-91
14. Lim KC, Lakshmanan G, Crawford SE, et al. 2000. Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. Nat. Genet. 25(2):209-12
15. Schuchardt A, D'Agati V, Larsson-Blomberg L, et al. 1994. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367(6461):380-83
16. James RG, Kamei CN,Wang Q, et al. 2006. Odd-skipped related 1 is required for development of the metanephric kidney and regulates formation and differentiation of kidney precursor cells. Development 133(15):2995-3004
17. Kochhar A, Fischer SM, Kimberling WJ, et al. 2007. Branchio-oto-renal syndrome. Am. J. Med. Genet. A 143A(14):1671-78
18. Kochhar A, Orten DJ, Sorensen JL, et al. 2008. SIX1 mutation screening in 247 branchio-oto-renal syndrome families: a recurrent missense mutation associated with BOR. Hum. Mutat. 29(4):565
19. Melnick M, Bixler D, Nance WE, et al. 1976. Familial branchio-oto-renal dysplasia: a new addition to the branchial arch syndromes. Clin. Genet. 9(1):25-34
20. Fraser FC, Sproule JR, Halal F. 1980. Frequency of the branchio-oto-renal (BOR) syndrome in children with profound hearing loss. Am. J. Med. Genet. 7(3):341-49
21. Chang EH, Menezes M, Meyer NC, et al. 2004. Branchio-oto-renal syndrome: the mutation spectrum in EYA1 and its phenotypic consequences. Hum. Mutat. 23(6):582-89
22. Izzedine H, Tankere F, Launay-Vacher V, et al. 2004. Ear and kidney syndromes: molecular versus clinical approach. Kidney Int. 65(2):369-85
23. Abdelhak S, Kalatzis V, Heilig R, et al. 1997. A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat. Genet. 15(2):157-64
24. Orten DJ, Fischer SM, Sorensen JL, et al. 2008. Branchio-oto-renal syndrome (BOR): novel mutations in the EYA1 gene, and a review of the mutational genetics of BOR. Hum. Mutat. 29(4):537-44
25. Kalatzis V, Sahly I, El-Amraoui A, et al. 1998. Eya1 expression in the developing ear and kidney: towards the understanding of the pathogenesis of branchio-oto-renal (BOR) syndrome. Dev. Dyn. 213(4):486-99
26. Ruf RG, Xu PX, Silvius D, et al. 2004. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc. Natl. Acad. Sci. USA 101(21):8090-95
27. Hoskins BE, Cramer CH, Silvius D, et al. 2007. Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome. Am. J. Hum. Genet. 80(4):800-4
28. Bilous RW,Murty G, Parkinson DB, et al. 1992. Brief report: autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia. N. Engl. J. Med. 327(15):1069-74
29. Van Esch H, Groenen P, Nesbit MA, et al. 2000. GATA3 haplo-insufficiency causes human HDR syndrome. Nature 406(6794):419-22
30. Labastie MC, Catala M, Gregoire JM, et al. 1995. The GATA-3 gene is expressed during human kidney embryogenesis. Kidney Int. 47(6):1597-603
31. van Looij MA, Meijers-Heijboer H, Beetz R, et al. 2006. Characteristics of hearing loss in HDR (hypoparathyroidism, sensorineural deafness, renal dysplasia) syndrome. Audiol. Neurootol. 11(6):373-79
32. Groves AK, Bronner-Fraser M. 2000. Competence, specification and commitment in otic placode induction. Development 127(16):3489-99
33. Eccles MR, Schimmenti LA. 1999. Renal-coloboma syndrome: a multi-system developmental disorder caused by PAX2 mutations. Clin. Genet. 56(1):1-9
34. Kohlhase J, Wischermann A, Reichenbach H, et al. 1998. Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome. Nat. Genet. 18(1):81-83
35. Bohm J, Munk-Schulenburg S, Felscher S, et al. 2006. SALL1 mutations in sporadic Townes-Brocks syndrome are of predominantly paternal origin without obvious paternal age effect. Am. J. Med. Genet. A 140(18):1904-8
36. Borozdin W, Steinmann K, Albrecht B, et al. 2006. Detection of heterozygous SALL1 deletions by quantitative real time PCR proves the contribution of a SALL1 dosage effect in the pathogenesis of Townes-Brocks syndrome. Hum. Mutat. 27(2):211-12
37. Nishinakamura R, Osafune K. 2006. Essential roles of Sall family genes in kidney development. J. Physiol. Sci. 56(2):131-36
38. Nishinakamura R, Matsumoto Y, Nakao K, et al. 2001. Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. Development 128(16):3105-15
39. Georgopoulos NA, Koika V, Galli-Tsinopoulou A, et al. 2007. Renal dysgenesis and KAL1 gene defects in patients with sporadic Kallmann syndrome. Fertil. Steril. 88(5):1311-17
40. Coatesworth AP, Woodhead CJ. 2002. Conductive hearing loss associated with Kallmann's syndrome. J. Laryngol. Otol. 116(2):125-26
41. Hardelin JP, Julliard AK, Moniot B, et al. 1999. Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome. Dev. Dyn. 215(1):26-44
42. Ernest S, Guadagnini S, Prevost MC, et al. 2007. Localization of anosmin-1a and anosmin-1b in the inner ear and neuromasts of zebrafish. Gene. Exp. Patterns 7(3):274-81
43. Ayari B, Soussi-Yanicostas N. 2007. FGFR1 and anosmin-1 underlying genetically distinct forms of Kallmann syndrome are coexpressed and interact in olfactory bulbs. Dev. Genes Evol. 217(2):169-75
44. Blacque OE, Reardon MJ, Li C, et al. 2004. Loss of C. elegans BBS-7 and BBS-8 protein function results in cilia defects and compromised intraflagellar transport. Genes Dev. 18(13):1630-42
45. Scholey JM. 2008. Intraflagellar transport motors in cilia: moving along the cell's antenna. J. Cell Biol. 180(1):23-29
46. Hildebrandt F, Otto E. 2005. Cilia and centrosomes: a unifying pathogenic concept for cystic kidney disease? Nat. Rev. Genet. 6(12):928-40
47. Germino GG. 2005. Linking cilia to Wnts. Nat. Genet. 37(5):455-57
48. Green JS, Parfrey PS, Harnett JD, et al. 1989. The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N. Engl. J. Med. 321(15):1002-9
49. Tobin JL, Beales PL. 2007. Bardet-Biedl syndrome: beyond the cilium. Pediatr. Nephrol. 22(7):926-36
50. Ansley SJ, Badano JL, Blacque OE, et al. 2003. Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 425(6958):628-33
51. Kim JC, Ou YY, Badano JL, et al. 2005. MKKS/BBS6, a divergent chaperonin-like protein linked to the obesity disorder Bardet-Biedl syndrome, is a novel centrosomal component required for cytokinesis. J. Cell Sci. 118(Pt. 5):1007-20
52. Beales PL, Elcioglu N, Woolf AS, et al. 1999. New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J. Med. Genet. 36(6):437-46
53. Ross AJ, May-Simera H, Eichers ER, et al. 2005. Disruption of Bardet-Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates. Nat. Genet. 37(10):1135-40
54. Marszalek JR, Ruiz-Lozano P, Roberts E, et al. 1999. Situs inversus and embryonic ciliary morphogenesis defects in mouse mutants lacking the KIF3A subunit of kinesin-II. Proc. Natl. Acad. Sci. USA 96(9):5043-48
55. Lin F, Hiesberger T, Cordes K, et al. 2003. Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proc. Natl. Acad. Sci. USA 100(9):5286-91
56. Patel V, Li L, Cobo-Stark P, et al. 2008. Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum. Mol. Genet. 17(11):1578-90
57. Murcia NS, Richards WG, Yoder BK, et al. 2000. The Oak Ridge polycystic kidney (orpk) disease gene is required for left-right axis determination. Development 127(11):2347-55
58. Lehman JM, Michaud EJ, Schoeb TR, et al. 2008. The Oak Ridge polycystic kidney mouse: modeling ciliopathies of mice and men. Dev. Dyn. 237(8):1960-71
59. Jones C, Roper VC, Foucher I, et al. 2008. Ciliary proteins link basal body polarization to planar cell polarity regulation. Nat. Genet. 40(1):69-77
60. Corbit KC, Shyer AE, Dowdle WE, et al. 2008. Kif3a constrains beta-catenin-dependent Wnt signalling through dual ciliary and nonciliary mechanisms. Nat. Cell Biol. 10(1):70-76
61. Park TJ, Haigo SL, Wallingford JB. 2006. Ciliogenesis defects in embryos lacking inturned or fuzzy function are associated with failure of planar cell polarity and Hedgehog signaling. Nat. Genet. 38(3):303-11
62. Gerdes JM, Liu Y, Zaghloul NA, et al. 2007. Disruption of the basal body compromises proteasomal function and perturbs intracellular Wnt response. Nat. Genet. 39(11):1350-60
63. Alstrom CH, Hallgren B, Nilsson LB, et al. 1959. Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl syndrome: a clinical, endocrinological and genetic examination based on a large pedigree. Acta Psychiatr. Neurol. Scand. Suppl. 129:1-35
64. Marshall JD, Beck S, Maffei P, et al. 2007. Alstrom syndrome. Eur. J. Hum. Genet. 15(12):1193-202
65. Hearn T, Renforth GL, Spalluto C, et al. 2002. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstrom syndrome. Nat. Genet. 31(1):79-83
66. Collin GB, Cyr E, Bronson R, et al. 2005. Alms1-disrupted mice recapitulate human Alstrom syndrome. Hum. Mol. Genet. 14(16):2323-33
67. Hildebrandt F, Zhou W. 2007. Nephronophthisis-associated ciliopathies. J. Am. Soc. Nephrol. 18(6):1855-71
68. Otto EA, Schermer B, Obara T, et al. 2003. Mutations inINVSencoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination. Nat. Genet. 34(4):413-20
69. Clarke MP, Sullivan TJ, Francis C, et al. 1992. Senior-Loken syndrome. Case reports of two siblings and association with sensorineural deafness. Br. J. Ophthalmol. 76(3):171-72
70. Caridi G, Dagnino M, Rossi A, et al. 2006. Nephronophthisis type 1 deletion syndrome with neurological symptoms: prevalence and significance of the association. Kidney Int. 70(7):1342-47
71. Karet FE, Gainza FJ, Gyory AZ, et al. 1998. Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc. Natl. Acad. Sci. USA 95(11):6337-42
72. Smith AN, Skaug J, Choate KA, et al. 2000. Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat. Genet. 26(1):71-75
73. Karet FE, Finberg KE, Nayir A, et al. 1999. Localization of a gene for autosomal recessive distal renal tubular acidosis with normal hearing (rdRTA2) to 7q33-34. Am. J. Hum. Genet. 65(6):1656-65
74. Stover EH, Borthwick KJ, Bavalia C, et al. 2002. Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J. Med. Genet. 39(11):796-803
75. Joshua B, Kaplan DM, Raveh E, et al. 2008. Audiometric and imaging characteristics of distal renal tubular acidosis and deafness. J. Laryngol. Otol. 122(2):193-98
76. Feldman M, Prikis M, Athanasiou Y, et al. 2006. Molecular investigation and long-term clinical progress in Greek Cypriot families with recessive distal renal tubular acidosis and sensorineural deafness due to mutations in the ATP6V1B1 gene. Clin. Genet. 69(2):135-44
77. Vargas-Poussou R, Houillier P, Le Pottier N, et al. 2006. Genetic investigation of autosomal recessive distal renal tubular acidosis: evidence for early sensorineural hearing loss associated with mutations in the ATP6V0A4 gene. J. Am. Soc. Nephrol. 17(5):1437-43
78. Hayama A, Rai T, Sasaki S, et al. 2003. Molecular mechanisms of Bartter syndrome caused by mutations in the BSND gene. Histochem. Cell Biol. 119(6):485-93
79. Uchida S, Sasaki S, Nitta K, et al. 1995. Localization and functional characterization of rat kidney-specific chloride channel, ClC-K1. J. Clin. Invest. 95(1):104-13
80. Kobayashi K, Uchida S, Mizutani S, et al. 2001. Intrarenal and cellular localization of CLC-K2 protein in the mouse kidney. J. Am. Soc. Nephrol. 12(7):1327-34
81. Boettger T, Hubner CA, Maier H, et al. 2002. Deafness and renal tubular acidosis in mice lacking the K-Cl cotransporter Kcc4. Nature 416(6883):874-78
82. Birkenhager R, Otto E, Schurmann MJ, et al. 2001. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat. Genet. 29(3):310-14
83. + secretion. Nature 414(6863):558-61
84. Schlingmann KP, Konrad M, Jeck N, et al. 2004. Salt wasting and deafness resulting from mutations in two chloride channels. N. Engl. J. Med. 350(13):1314-19
85. Gubler MC, Heidet L, Antignac C. 2007. Alport syndrome or progressive hereditary nephritis with hearing loss. Nephrol. Ther. 3(3):113-20
86. Pescucci C, Mari F, Longo I, et al. 2004. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. Kidney Int. 65(5):1598-603
87. Kashtan CE. 2007. Alport syndrome and the X chromosome: implications of a diagnosis of Alport syndrome in females. Nephrol. Dial. Transpl. 22(6):1499-505
88. Jais JP, Knebelmann B, Giatras I, et al. 2003. X-linked Alport syndrome: natural history and genotypephenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study. J. Am. Soc. Nephrol. 14(10):2603-10
89. Zehnder AF, Adams JC, Santi PA, et al. 2005. Distribution of type IV collagen in the cochlea in Alport syndrome. Arch. Otolaryngol. Head Neck Surg. 131(11):1007-13
90. Smyth A, Lewis S, Bertenshaw C, et al. 2008. Case-control study of acute renal failure in patients with cystic fibrosis in the UK. Thorax 63(6):532-35
91. Echeverria P, Fina D, Norton S, et al. 1978. Ototoxicity of gentamicin: clinical experience in a children's hospital. Chemotherapy 24(4):267-71
92. Dai CF, Steyger PS. 2008. A systemic gentamicin pathway across the stria vascularis. Hear. Res. 235(1-2):114-24
93. Myrdal SE, Steyger PS. 2005. TRPV1 regulators mediate gentamicin penetration of cultured kidney cells. Hear. Res. 204(1-2):170-82
94. Feldman L, Efrati S, Eviatar E, et al. 2007. Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine. Kidney Int. 72(3):359-63
95. Bitner-Glindzicz M, Rahman S. 2007. Ototoxicity caused by aminoglycosides. BMJ 335(7624):784-85
96. Bai YH, Ren CC, Gong XR, et al. 2008. A maternal hereditary deafness pedigree of the A1555G mitochondrial mutation, causing aminoglycoside ototoxicity predisposition. J. Laryngol. Otol. 19:1-5
97. Launay-Vacher V, Rey JB, Isnard-Bagnis C, et al. 2008. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer Chemother. Pharmacol. 61(6):903-9
98. Dean JB, Hayashi SS, Albert CM, et al. 2008. Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens. J. Pediatr. Hematol. Oncol. 30(2):130-34
99. Thomas JP, Lautermann J, Liedert B, et al. 2006. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity. Mol. Pharmacol. 70(1):23-29
100. Sheikh-Hamad D. 2008. Cisplatin-induced cytoxicity: Is the nucleus relevant? Am. J. Physiol. Renal Physiol. 295(1):F42-43